Immunogenic and protective Candida albicans constituents

Research in Immunology

Volumn 149, Issue 4-5, 1998, Pages 289-299

  Cassone, A ^a   De Bernardis, F ^a   Ausiello, C M ^a   Gomez, M J ^a   Boccanera, M ^a   La Valle, R ^a   Torosantucci, A ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL ACTIVITY; CANDIDA ALBICANS; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOMODULATION; IMMUNOSURVEILLANCE; MYCOSIS; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; VAGINITIS; VIRULENCE;

EID: 0032077840     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80753-0     Document Type: Article

References (51)

1. Allendoerfer, R., Maresca, B. & Deepe, G.S. (1996), Cellular immune responses to recombinant heat shock protein 70 from Histoplasma capsulatum. Infect. Immun., 64, 4123-4128.
2. Arancia, G., Molinari, A., Crateri, P., Stringaro, A., Ramoni, C., Dupuis, M.L., Gomez, M.J., Torosantucci, A. & Cassone, A. (1995), Noninhibitory binding of human interleukin-2-activated natural killer cells to the germ tube forms of Candida albicans. Infect. Immun., 63, 280-288.
3. Bistoni, F., Vecchiarelli, A., Cenci, E., Puccetti, P., Marconi, P. & Cassone, A. (1986), Evidence for macrophage-mediated protection against lethal C. albicans infection. Infect. Immun., 51, 668-674.
4. Bodey, G.P., Buckley, M., Sathe, Y.S. & Freireich, E.J. (1986), Quantitative relationship between circulating leukocytes and infection in patients with acute leukemia. Ann. Inter. Med., 64, 328-340.
5. Bromuro, C., La Valle, R., Sandini, S., Urbani, F., Ausiello, C.M., Morelli, L., Fe d'Ostiani, C., Romani, L. & Cassone, A. (1998), A 70kDa recombinant heat shock protein of C. albicans is highly immunogenic and enhances systemic murine candidiasis. Infect. Immun., 66, 2154-2162.
6. Casadevall, A. (1995), Antibody immunity and invasive fungal infections. Infect. Immun., 63, 4211-4218.
7. Casadevall, A., Cassone, A., Bistoni, F., Cutler, J.E., Magliani, W., Murphy, J.W., Polonelli, L. & Romani, L. (1998), Antibody-and or cell-mediated immunity-protective mechanisms in fungal disease: an ongoing dilemma or an unecessary dispute? J. Med. Vet. Mycol. (in press).
8. Cassone, A., De Bernardis, F., Mondello, F., Ceddia, T. & Agatensi, L. (1987), Evidence for a correlation between proteinase secretion and vulvovaginal candidosis. J. Infect. Dis., 156, 777-783.
9. Cassone, A., Torosantucci, A., Boccanera, M., Pellegrini, G., Palma, C. & Malavasi, F. (1988), Production and characterization of a monoclonal antibody to a cell surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species. J. Med. Microbiol., 27, 233-238.
10. Cassone, A. (1995), Immunogenic and immunomodulatory properties of mannoproteins from Candida albicans. Can. J. Bot., 73, 1192-1198.
11. Cassone, A., Boccanera, M., Adriani, D., Santoni, D. & De Bernardis, F. (1995), Rats clearing a vaginal infections by Candida albicans acquire specific, antibody-mediated resistance to vaginal reinfection. Infect. Immun., 63, 2619-2624.
12. Cassone, A., Conti, S., De Bernardis, F. & Polonelli, L. (1997a), Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature? Immunol. Today, 18, 164-169.
13. Cassone, A., Chiani, P., Quinti, I. & Torosantucci, A. (1997b), Possible participation of polymorphonuclear cells stimulated by microbial immunomodulators in the dysregulated cytokine patterns of AIDS patients. J. Leuk. Biol., 62, 60-66.
14. Coffman, R.L., Lebman, D.A. & Rothman, P. (1993), Adv. Immunol., 54, 229-270.
15. Cutler, J.E. (1991), Putative virulence factors of Candida albicans. Annu. Rev. Microbiol., 45, 187-218.
16. De Bernardis, F., Molinari, A., Boccanera, M., Stringaro A., Robert, R., Senet, J.M., Arancia, G. & Cassone, A. (1994), Modulation of cell surface-associated mannoprotein antigen expression in experimental candidal vaginitis. Infect. Immun., 62, 509-519.
17. De Bernardis, F., Cassone, A., Sturtevant, J. & Calderone, R. (1995), Expression of Candida albicans SAP1 and SAP2 in experimental vaginitis. Infect. Immun., 62, 1887-1892.
18. De Bernardis, F., Chiani, P., Ciccozzi, M., Pellegrini, G., Ceddia D'Offizi, G., Quinti, I., Sullivan, F.A. & Cassone, A. (1996), Elevated aspartic proteinase secretion and experimental pathogenicity of Candida albicans isolated from oral cavities of HIV-infected subjects. Infect. Immun., 64, 466-451.
19. De Bernardis, F., Boccanera, M., Adriani, D., Spreghini, E., Santoni G. & Cassone, A. (1997), Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats. Infect. Immun., 65, 3399-3405.
20. De Bernardis, F., Arancia, S., Morelli, L., Hube, B., Sanglard, D., Schafer, W. & Cassone, A. (1998a), Evidence that members of the secretory aspartyl proteinases gene family (SAP), in particular SAP2, are virulence factors for Candida vaginitis. J. Infect. Dis. (in press).
21. De Bernardis, F., Muehlschlegel, F.A., Cassone, A. & Fonzi, W.A. (1998b), The pH of the host niche controls gene expression in and virulence of Candida albicans. Infect. Immun., 66 (in press).
22. Deepe, G.S., Jr. (1997), Prospects for the development of fungal vaccines. Clin. Microbiol. Rev., 10, 585-596.
23. Domer, J.E. (1989), Candida cell wall mannan: a polysaccharide with diverse immunologic properties. Crit. Rev. Immunol., 17, 33-51.
24. Fidel, P.L., Jr., Lynch, M.E., Conaway, D.H., Tait, L. & Sobel, J.D. (1995), Mice immunized by primary vaginal Candida albicans infection develop acquired vaginal mucosal immunity. Infect. Immun., 63, 547-553.
25. Fidel, P.L., Jr., Wolf, N.A. & Kukuruga, M.A. (1996), T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect. Immun., 3793-3799.
26. Ghadjari, A., Matthews, R.C. & Burnie, J.P. (1997), Epitope mapping of Candida albicans proteinase (SAP2). FEMS Immunol. Med. Microbiol., 19, 115-123.
27. Gomez, M.J., Torosantucci, A., Arancia, S., Maras, B., Parisi, L. & Cassone, A. (1996), Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans. Infect. Immun., 64, 2577-2584.
28. Han, Y. & Cutler, J.E. (1995), Antibody response that protects against disseminated candidiasis. Infect. Immun., 63, 2714-2719.
29. Hube, B. (1996), Candida albicans secreted aspartyl proteinases. Curr. Top. Med. Mycol., 7, 55-69.
30. Klein, R.S., Harris, C.A., Small, C.B., Moll, B., Lesser, M. & Friedland, G.H. (1984), Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N. Engl. J. Med., 311, 354-358.
31. La Valle, R., Bromuro, C., Ranucci, L., Muller, H.M., Crisanti, A. & Cassone, A. (1995), Molecular cloning and expression of 70kDa heat shock protein of Candida albicans. Infect. Immun., 63, 4039-4045.
32. Matthews, R., Smith, D., Midgley, J., Burnie, J., Clark, I., Conolly, M. & Gazzard, B. (1988), Candida and AIDS: evidence for protective antibody. Lancet, 30, 263-265.
33. Mathews, R. & Burnie, J. (1992), The role of hsp90 in fungal infection. Immunol. Today, 13, 345-348.
34. Mencacci, A., Torosantucci, A., Spaccapelo, R., Romani, L., Bistoni, F. & Cassone, A. (1994), A mannoprotein constituents of Candida albicans that elicit different levels of delayed-type hypersensitivity, cytokine production, and anticandidal protection in mice. Infect. Immun., 62, 5353-5360.
35. + T helper type 1 cell responses to Candida albicans. J. Exp. Med., 187, 307-317.
36. Murray, P.D., Jwain, S.L. & Kagnoff, M.P. (1985), J. Immunol., 135, 4015-4020.
37. Odds, F.C. (1988), Candida and candidosis. Bailliere Tindall, London.
38. Ponton, J., Marot-Leblond, A., Ezkurra, P.A., Barturen, B., Robert, R. & Senet, J.M. (1993), Characterization of Candida albicans cell wall antigens with monoclonal antibodies. Infect. Immun., 61, 4842-4847.
39. H2-like switch in candidiasis: new perspectives for therapy. Trends Microbiol., 3, 237-240.
40. + subset expression in murine candidiasis. Infect. Immun., 60, 4950-4952.
41. Romani, L., Mencacci, A., Grohmann, U., Mocci, S., Mosci, P., Puccetti, P. & Bistoni, F. (1992b), Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med., 176, 19-25.
42. Romani, L., Mencacci, A., Tonnetti, L., Spaccapelo, R., Cenci, E., Puccetti, P., Wolf, S.F. & Bistoni, F. (1994), Interleukin-12 is both required and prognostic in vivo for T helper type 1 differentiation in murine candidiasis. J. Immunol., 153, 5157-5175.
43. Romani, L. & Howard, D.H. (1995), Mechanisms of resistance to fungal infection. Curr. Opin. Immunol., 7, 517-523.
44. + T helper cell 1 development in interleukin-6-deficient mice infected with Candida albicans. J. Exp. Med., 183, 1-11.
45. Romani, L., Bistoni, F., Mencacci, A., Cenci, E., Spaccapelo, R. & Puccetti, P. (1996b), IL12 in Candida albicans infections. Res. Immunol., 146, 532-538.
46. Shibata, N., Ikuta, K., Imai, T., Satoh, Y., Satoh, R., Suzuki, A., Kojima, C., Kobayashi, H., Hisamici, K. & Suzuki, S. (1995), Existence of branched side chains in the cell wall mannan of pathogenic yeast, Candida albicans. Structure-antigenicity relationship between the cell wall mannans of Candida albicans and Candida parapsilosis. J. Biol. Chem., 270, 1113-1122.
47. Sobel, J.D. (1992), Pathogenesis and treatment of recurrent vulvovaginal candidiasis. Clin. Infect. Dis., 14, 5148-5153.
48. Sundstrom, P., Jensen, T. & Balish, F. (1994), Humoral and cellular immune response to enolase after alimentary tract colonization or intravenous immunization with Candida albicans. J. Infect. Dis., 170, 390-395.
49. Torosantucci, A., Bromuro, C., Gomez, M.J., Ausiello, C.M., Urbani, F. & Cassone, A. (1993), Identification of a 65-kDa mannoprotein as a main target of human cell-mediated immune response to Candida albicans. J. Infect. Dis., 168, 427-435.
50. Torosantucci, A., Chiani, P., Quinti, I., Ausiello, C.M., Mezzaroma, I. & Cassone, A. (1997), Responsiveness of human polymorphonuclear cells (PMNL) to stimulation by a mannoprotein fraction (MP-F2) of Candida albicans; enhanced production of EL-6 and tumour necrosis factor-alpha (TNF-α) by MP-F2-stimulated PMNL from HIV-infected subjects. Clin. Exp. Immunol., 107, 451-457.
51. Trinel, P.A., Borg-von Zepelin, Legage G., Jonault, T., MacKenzie, D. & Poulain, D. (1993), Isolation and preliminary characterization of the 14-to 18-kilodalton Candida albicans antigen as a phospholipomannan containing beta 1-2 linked oligomannosides. Infect. Immun., 61, 4398-4405.